Contrary to previous retrospective studies, the use of ureteroscopy maynot be the best option for larger lower-pole stones, according to findingsfrom a prospective, randomized study presented here yesterday. Results fromthe multicenter study suggest that other treatment modalities, such as percutaneousnephrolithotomy, may offer greater efficacy in stones >10 mm.
Study identifies 11 gene mutations linked to aggressive prostate cancer
October 3rd 2023This is the largest prostate cancer study that examined the exome, according to the researchers, who believe their findings can potentially inform the makeup of panels used for genetic testing in prostate cancer.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.
2 Clarke Drive
Cranbury, NJ 08512